Related references
Note: Only part of the references are listed.Mechanisms controlling pancreatic islet cell function in insulin secretion
Jonathan E. Campbell et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
Ting Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice
Hao Chiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
Loranne Agius et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effects of Empagliflozin Treatment on Glycerol-Derived Hepatic Gluconeogenesis in Adults with Obesity: A Randomized Clinical Trial
Ian J. Neeland et al.
OBESITY (2020)
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Chenguang Li et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Inhibition of microRNA-124a attenuates non-alcoholic fatty liver disease through upregulation of adipose triglyceride lipase and the effect of liraglutide intervention
Qian-Hua Fang et al.
HEPATOLOGY RESEARCH (2019)
Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice
Mei Xue et al.
CLINICAL SCIENCE (2019)
AMPK: guardian of metabolism and mitochondrial homeostasis
Sebastien Herzig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
Hiddo J. L. Heerspink et al.
KIDNEY INTERNATIONAL (2018)
Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
Hao Zhou et al.
REDOX BIOLOGY (2018)
PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels
Bo-Yoon Park et al.
DIABETES (2018)
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
Liang Xu et al.
EBIOMEDICINE (2017)
Renal glucose metabolism in normal physiological conditions and in diabetes
Mazen Alsahli et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes
Tong-Yan Liu et al.
CLINICAL SCIENCE (2015)
Daytime restricted feeding modifies the daily variations of liver gluconeogenesis: Adaptations in biochemical and endocrine regulators
Moises Perez-Mendoza et al.
CHRONOBIOLOGY INTERNATIONAL (2014)
GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice
Qian Wang et al.
CLINICAL SCIENCE (2014)
Independent and combined effects of acute physiological hyperglycaemia and hyperinsulinaemia on metabolic gene expression in human skeletal muscle
Kostas Tsintzas et al.
CLINICAL SCIENCE (2013)
Regulation of Hepatic Glucose Uptake and Storage In Vivo
Mary Courtney Moore et al.
ADVANCES IN NUTRITION (2012)
The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPK Pathways
Dan Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Protein Acetylation Microarray Reveals that NuA4 Controls Key Metabolic Target Regulating Gluconeogenesis
Yu-yi Lin et al.
CELL (2009)
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
Songping Han et al.
DIABETES (2008)
AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3β and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver
Nanao Horike et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP
Yong Deuk Kim et al.
DIABETES (2008)
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
SH Koo et al.
NATURE (2005)
Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis
R Basu et al.
DIABETES (2005)
Share Paper
